- Overview
- News
- Biographies
- Speeches
- Photos
- TV Footage
-
Publications
- Overview
- Integrated Annual Reports
- Quarterly Reports
- Bayer Magazine
- BEENOW Magazine
- Farming’s Future Magazine
- research Magazine
- technology solutions Magazine
- From Molecules to Medicine
- From Molecules to Veterinary Medicines Brochure
- Integrated Weed Management
- Names | Figures | Facts
- Transfers of Value to Physicians Brochure
- Newsletter Overview
- Videos
- Social Media
- Apps
- Events
- Background Information
- E-Cards
- Media Contact
Board of Management
Biografien
Kemal Malik
Member of the Board of Management of Bayer AG
Kemal Malik was appointed to the Board of Management of Bayer AG effective February 1, 2014. He is responsible for Innovation and the Latin America regions.
Kemal Malik was born in Slough, United Kingdom, on September 29, 1962. He studied medicine in London, graduating as a Bachelor of Medicine, Bachelor of Surgery (MBBS) in 1987. Malik subsequently spent several years in clinical medicine at the Northwick Park Clinical Research Centre and at Hammersmith Hospital, London. He then held various positions of increasing responsibility in medical affairs and clinical development at Bristol-Myers Squibb.
Malik joined Bayer in 1995 as Head of Metabolism and Oncology Europe in the then Pharmaceuticals Business Group. He subsequently served as Head of Global Medical Development before being appointed Head of Global Development and a member of the Executive Committee of Bayer HealthCare AG until his appointment to the Board of Management of Bayer AG.
Kemal Malik was born in Slough, United Kingdom, on September 29, 1962. He studied medicine in London, graduating as a Bachelor of Medicine, Bachelor of Surgery (MBBS) in 1987. Malik subsequently spent several years in clinical medicine at the Northwick Park Clinical Research Centre and at Hammersmith Hospital, London. He then held various positions of increasing responsibility in medical affairs and clinical development at Bristol-Myers Squibb.
Malik joined Bayer in 1995 as Head of Metabolism and Oncology Europe in the then Pharmaceuticals Business Group. He subsequently served as Head of Global Medical Development before being appointed Head of Global Development and a member of the Executive Committee of Bayer HealthCare AG until his appointment to the Board of Management of Bayer AG.
Download
Pictures (High-Res)
Download Pictures Add to Download Center
News Release
Download PDFDownload RTFAdd PDF (18 KB) to Download Center
Add RTF (54 KB) to Download Center
